CIVCO Releases Non-Invasive Stereotactic Radiosurgery (SRS) Solution for Head and Brain Tumors
CORALVILLE, Iowa, Feb. 27, 2013 /PRNewswire/ — CIVCO Medical Solutions, the leading provider of radiation oncology motion management solutions, announced today the release of trUpoint ARCH(TM), a new stereotactic radiosurgery (SRS) and stereotactic fractionated radiation (SRT) solution for head and brain tumors.
Stereotactic radiosurgery involves delivering very high doses of radiation quickly, using precisely shaped beams that focus on the tumor and minimize exposure of surrounding healthy tissues and organs. trUpoint ARCH is a frameless solution designed to effectively stabilize a patient’s head in a non-invasive, comfortable hold for delivering the high radiation doses.
“trUpoint ARCH is a solution that produces repeatable results for radiosurgery patients requiring absolute positioning. Our focus when developing new patient positioning and immobilization products is patient comfort and ease of set-up for the clinician; this solution delivers both,” said Nat Geissel, senior vice president and general manager of CIVCO’s radiation oncology business unit.
The trUpoint ARCH system provides clinicians a simple and manageable patient set-up assuring accuracy and repeatability during SRS and SRT treatments. Indexing is available on the device, nasion, and the arch design allows flexibility in treatment planning around the device. Compatible with CIVCO’s Universal Couchtop(TM), Posifix® thermoplastic system, AccuForm(TM) cushions and Protura(TM) Robotic Patient Positioning System, trUpoint ARCH provides a comprehensive motion management solution for effective SRS/SRT treatment.
The first cancer center to benefit from this innovative solution is the University Hospital Zurich, Switzerland. They began using trUpoint ARCH with their radiosurgery program in late January 2013.
CIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. CIVCO’s Radiation Oncology (RO) division designs, manufactures and markets comprehensive motion management solutions to improve patient outcomes and increase clinical productivity for head & neck, breast, lung, abdomen, prostate and other treatment sites. RO’s products include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI’s products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO offers patients and clinicians the newest and best technology available to improve patient care.
Corporate information is available at www.CIVCO.com.
For further information please contact:
Marketing Communications Specialist
CIVCO Medical Solutions
COPYRIGHT© 2013. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. PROTURA AND ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNERS. NOT ALL PRODUCTS MAY BE AVAILABLE IN ALL MARKETS. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2013C0847
SOURCE CIVCO Medical Solutions